Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ketamine | 11 | 2024 | 516 | 4.760 |
Why?
|
Bipolar Disorder | 31 | 2023 | 5083 | 4.450 |
Why?
|
Electroconvulsive Therapy | 10 | 2024 | 500 | 3.280 |
Why?
|
Depressive Disorder, Major | 23 | 2023 | 4745 | 3.000 |
Why?
|
Antidepressive Agents | 9 | 2023 | 2889 | 1.480 |
Why?
|
Lithium | 5 | 2023 | 596 | 1.370 |
Why?
|
Amygdala | 7 | 2018 | 1351 | 1.270 |
Why?
|
Emotions | 9 | 2020 | 2734 | 1.110 |
Why?
|
Facial Expression | 5 | 2020 | 508 | 0.890 |
Why?
|
Reflex Sympathetic Dystrophy | 2 | 2013 | 58 | 0.800 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 2 | 2017 | 415 | 0.800 |
Why?
|
Lithium Compounds | 4 | 2023 | 225 | 0.790 |
Why?
|
Memantine | 2 | 2013 | 106 | 0.780 |
Why?
|
Dopamine Agents | 2 | 2013 | 189 | 0.770 |
Why?
|
Depression | 13 | 2023 | 8057 | 0.730 |
Why?
|
Triazines | 2 | 2013 | 310 | 0.710 |
Why?
|
Corpus Striatum | 4 | 2016 | 1233 | 0.690 |
Why?
|
Brain | 19 | 2022 | 26951 | 0.670 |
Why?
|
Affective Symptoms | 2 | 2018 | 416 | 0.640 |
Why?
|
Magnetic Resonance Imaging | 28 | 2022 | 36285 | 0.640 |
Why?
|
Psychiatric Status Rating Scales | 11 | 2020 | 6013 | 0.620 |
Why?
|
Nerve Net | 4 | 2018 | 2263 | 0.610 |
Why?
|
Analgesics | 3 | 2020 | 1064 | 0.600 |
Why?
|
Antimanic Agents | 4 | 2023 | 520 | 0.600 |
Why?
|
Transsexualism | 1 | 2020 | 206 | 0.540 |
Why?
|
Cerebral Cortex | 5 | 2016 | 5759 | 0.490 |
Why?
|
Sertraline | 3 | 2007 | 208 | 0.490 |
Why?
|
Brain Mapping | 10 | 2020 | 6570 | 0.460 |
Why?
|
Impulsive Behavior | 1 | 2017 | 346 | 0.460 |
Why?
|
Anticonvulsants | 3 | 2020 | 1881 | 0.420 |
Why?
|
Neural Pathways | 6 | 2018 | 3040 | 0.420 |
Why?
|
Limbic System | 3 | 2009 | 419 | 0.380 |
Why?
|
Prefrontal Cortex | 3 | 2017 | 2209 | 0.380 |
Why?
|
Rest | 1 | 2016 | 914 | 0.380 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2015 | 285 | 0.380 |
Why?
|
Creatine | 1 | 2013 | 426 | 0.370 |
Why?
|
Anxiety Disorders | 3 | 2020 | 2714 | 0.370 |
Why?
|
Humans | 71 | 2024 | 758381 | 0.330 |
Why?
|
Adult | 39 | 2024 | 219916 | 0.330 |
Why?
|
Affect | 3 | 2007 | 1480 | 0.330 |
Why?
|
Models, Neurological | 2 | 2016 | 1757 | 0.310 |
Why?
|
Image Processing, Computer-Assisted | 9 | 2017 | 8946 | 0.310 |
Why?
|
Executive Function | 1 | 2017 | 1375 | 0.300 |
Why?
|
Lactic Acid | 1 | 2013 | 1133 | 0.300 |
Why?
|
Pattern Recognition, Visual | 1 | 2013 | 810 | 0.290 |
Why?
|
Young Adult | 16 | 2022 | 58808 | 0.290 |
Why?
|
Opioid-Related Disorders | 1 | 2022 | 2142 | 0.290 |
Why?
|
Motor Activity | 1 | 2017 | 2686 | 0.280 |
Why?
|
Adolescent | 20 | 2022 | 87888 | 0.280 |
Why?
|
Electric Stimulation Therapy | 1 | 2012 | 613 | 0.280 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3765 | 0.260 |
Why?
|
Female | 42 | 2024 | 390316 | 0.260 |
Why?
|
Male | 40 | 2024 | 358742 | 0.260 |
Why?
|
Treatment Outcome | 17 | 2024 | 64379 | 0.260 |
Why?
|
Photic Stimulation | 5 | 2013 | 1967 | 0.260 |
Why?
|
Primary Health Care | 2 | 2020 | 4653 | 0.250 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2013 | 3758 | 0.240 |
Why?
|
Pharmacogenetics | 3 | 2023 | 675 | 0.220 |
Why?
|
Case-Control Studies | 8 | 2018 | 22031 | 0.220 |
Why?
|
Mood Disorders | 3 | 2014 | 1124 | 0.220 |
Why?
|
Antipsychotic Agents | 1 | 2016 | 3060 | 0.220 |
Why?
|
Isoxazoles | 1 | 2005 | 230 | 0.220 |
Why?
|
Arousal | 1 | 2009 | 1157 | 0.210 |
Why?
|
Focal Adhesions | 1 | 2023 | 114 | 0.210 |
Why?
|
Oxygen Consumption | 1 | 2009 | 1846 | 0.210 |
Why?
|
Middle Aged | 24 | 2024 | 219560 | 0.200 |
Why?
|
Mental Health | 1 | 2017 | 3232 | 0.200 |
Why?
|
Wounds and Injuries | 1 | 2014 | 2476 | 0.200 |
Why?
|
Disease Progression | 1 | 2018 | 13468 | 0.190 |
Why?
|
Substance-Related Disorders | 3 | 2018 | 4402 | 0.190 |
Why?
|
Depressive Disorder | 3 | 2018 | 3727 | 0.190 |
Why?
|
Glutamic Acid | 3 | 2013 | 1167 | 0.190 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 7985 | 0.180 |
Why?
|
Endophenotypes | 1 | 2022 | 255 | 0.170 |
Why?
|
Psychomotor Performance | 3 | 2013 | 1878 | 0.170 |
Why?
|
Suicide | 2 | 2020 | 1598 | 0.160 |
Why?
|
Diffusion Tensor Imaging | 3 | 2022 | 2387 | 0.160 |
Why?
|
Personality Inventory | 3 | 2019 | 1018 | 0.160 |
Why?
|
Iatrogenic Disease | 1 | 2021 | 538 | 0.150 |
Why?
|
Pilot Projects | 3 | 2020 | 8554 | 0.150 |
Why?
|
Double-Blind Method | 5 | 2019 | 12262 | 0.150 |
Why?
|
Oxygen | 4 | 2016 | 4192 | 0.150 |
Why?
|
Midazolam | 1 | 2019 | 266 | 0.140 |
Why?
|
Drug Therapy, Combination | 4 | 2013 | 6293 | 0.140 |
Why?
|
Reward | 2 | 2015 | 965 | 0.140 |
Why?
|
Gyrus Cinguli | 3 | 2009 | 1115 | 0.140 |
Why?
|
Personality | 1 | 2019 | 552 | 0.130 |
Why?
|
Outpatients | 1 | 2023 | 1591 | 0.130 |
Why?
|
Arthroscopy | 1 | 2022 | 960 | 0.130 |
Why?
|
Comorbidity | 3 | 2020 | 10495 | 0.120 |
Why?
|
Epilepsy | 2 | 2020 | 3269 | 0.120 |
Why?
|
Putamen | 1 | 2016 | 291 | 0.120 |
Why?
|
Infusions, Intravenous | 1 | 2019 | 2210 | 0.120 |
Why?
|
Gender Identity | 1 | 2020 | 757 | 0.120 |
Why?
|
Gene Regulatory Networks | 1 | 2023 | 1740 | 0.120 |
Why?
|
International Cooperation | 2 | 2018 | 1430 | 0.110 |
Why?
|
Neuropsychological Tests | 3 | 2020 | 7023 | 0.110 |
Why?
|
Neostriatum | 1 | 2015 | 246 | 0.110 |
Why?
|
Telemedicine | 2 | 2022 | 3018 | 0.110 |
Why?
|
Anesthetics | 1 | 2019 | 522 | 0.110 |
Why?
|
International Classification of Diseases | 1 | 2018 | 892 | 0.110 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2018 | 574 | 0.110 |
Why?
|
Cocaine | 2 | 2011 | 958 | 0.110 |
Why?
|
Trauma Severity Indices | 1 | 2014 | 478 | 0.110 |
Why?
|
Delayed-Action Preparations | 1 | 2016 | 961 | 0.110 |
Why?
|
Tritium | 1 | 2013 | 707 | 0.110 |
Why?
|
Membrane Potentials | 1 | 2016 | 1094 | 0.100 |
Why?
|
Hippocampus | 2 | 2018 | 3736 | 0.100 |
Why?
|
Behavior, Addictive | 1 | 2018 | 462 | 0.100 |
Why?
|
Circadian Rhythm | 3 | 2018 | 2567 | 0.100 |
Why?
|
Registries | 2 | 2019 | 8176 | 0.100 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2018 | 1988 | 0.100 |
Why?
|
Pain, Postoperative | 1 | 2022 | 1721 | 0.100 |
Why?
|
Borderline Personality Disorder | 1 | 2018 | 765 | 0.090 |
Why?
|
Psychotic Disorders | 2 | 2023 | 3197 | 0.090 |
Why?
|
Calcium Channels | 1 | 2015 | 618 | 0.090 |
Why?
|
Aspartic Acid | 1 | 2013 | 576 | 0.090 |
Why?
|
Child | 9 | 2021 | 79813 | 0.090 |
Why?
|
Aftercare | 1 | 2016 | 910 | 0.090 |
Why?
|
Carbon Isotopes | 1 | 2011 | 458 | 0.090 |
Why?
|
Cognition | 3 | 2020 | 6955 | 0.090 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 3 | 2004 | 1066 | 0.090 |
Why?
|
Genome-Wide Association Study | 2 | 2023 | 12604 | 0.090 |
Why?
|
Mental Health Services | 1 | 2022 | 1718 | 0.090 |
Why?
|
Heterozygote | 1 | 2017 | 2797 | 0.090 |
Why?
|
Dopamine Uptake Inhibitors | 1 | 2011 | 297 | 0.080 |
Why?
|
Thalamus | 1 | 2016 | 1040 | 0.080 |
Why?
|
Mediodorsal Thalamic Nucleus | 1 | 2009 | 12 | 0.080 |
Why?
|
Risk-Taking | 1 | 2015 | 1034 | 0.080 |
Why?
|
Frontal Lobe | 1 | 2016 | 1419 | 0.080 |
Why?
|
Risk | 2 | 2018 | 9599 | 0.080 |
Why?
|
Age Distribution | 1 | 2015 | 2882 | 0.080 |
Why?
|
Regression Analysis | 2 | 2018 | 6353 | 0.080 |
Why?
|
Pituitary Gland | 1 | 2011 | 637 | 0.080 |
Why?
|
Self Report | 1 | 2020 | 3712 | 0.080 |
Why?
|
Fibroblasts | 1 | 2018 | 4087 | 0.080 |
Why?
|
Bariatric Surgery | 1 | 2018 | 986 | 0.070 |
Why?
|
Age of Onset | 1 | 2015 | 3298 | 0.070 |
Why?
|
Alcoholism | 1 | 2018 | 1964 | 0.070 |
Why?
|
Globus Pallidus | 1 | 2009 | 250 | 0.070 |
Why?
|
Dominance, Cerebral | 1 | 2009 | 622 | 0.070 |
Why?
|
Gene Expression | 1 | 2020 | 7583 | 0.070 |
Why?
|
Aged | 8 | 2024 | 168217 | 0.070 |
Why?
|
Adolescent Behavior | 1 | 2015 | 1184 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 12951 | 0.070 |
Why?
|
Excitatory Amino Acid Transporter 2 | 1 | 2007 | 89 | 0.060 |
Why?
|
Longitudinal Studies | 2 | 2020 | 14481 | 0.060 |
Why?
|
Huntington Disease | 1 | 2012 | 1141 | 0.060 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2010 | 600 | 0.060 |
Why?
|
Reaction Time | 1 | 2011 | 2075 | 0.060 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2018 | 1852 | 0.060 |
Why?
|
Diencephalon | 1 | 2004 | 54 | 0.060 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 3701 | 0.060 |
Why?
|
Bayes Theorem | 1 | 2013 | 2322 | 0.060 |
Why?
|
Suicidal Ideation | 1 | 2014 | 1430 | 0.060 |
Why?
|
Research Design | 1 | 2020 | 6154 | 0.060 |
Why?
|
Pindolol | 1 | 2004 | 33 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2013 | 15785 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 25953 | 0.060 |
Why?
|
Reference Values | 2 | 2009 | 4919 | 0.060 |
Why?
|
Corpus Callosum | 1 | 2009 | 749 | 0.060 |
Why?
|
Visual Perception | 1 | 2012 | 1374 | 0.060 |
Why?
|
Flumazenil | 1 | 2003 | 84 | 0.060 |
Why?
|
Inpatients | 1 | 2014 | 2551 | 0.050 |
Why?
|
Seasonal Affective Disorder | 1 | 2002 | 49 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 10146 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 13286 | 0.050 |
Why?
|
Decision Making | 1 | 2015 | 3915 | 0.050 |
Why?
|
Catecholamines | 1 | 2002 | 385 | 0.050 |
Why?
|
Serotonin | 2 | 2004 | 1040 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2007 | 6233 | 0.050 |
Why?
|
Genotype | 1 | 2015 | 12945 | 0.040 |
Why?
|
Bilirubin | 1 | 2002 | 437 | 0.040 |
Why?
|
Tomography, Emission-Computed | 1 | 2003 | 1121 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2018 | 15773 | 0.040 |
Why?
|
Psychotropic Drugs | 1 | 2005 | 883 | 0.040 |
Why?
|
Receptors, GABA-A | 1 | 2003 | 621 | 0.040 |
Why?
|
Retrospective Studies | 5 | 2022 | 80170 | 0.040 |
Why?
|
Astrocytes | 1 | 2007 | 1337 | 0.040 |
Why?
|
Phototherapy | 1 | 2002 | 368 | 0.040 |
Why?
|
Behavior, Animal | 1 | 2007 | 1867 | 0.040 |
Why?
|
Membrane Transport Proteins | 1 | 2004 | 1034 | 0.040 |
Why?
|
Inositol 1,4,5-Trisphosphate Receptors | 1 | 2018 | 89 | 0.040 |
Why?
|
Parkinson Disease | 1 | 2012 | 2862 | 0.040 |
Why?
|
Period Circadian Proteins | 1 | 2018 | 96 | 0.040 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2004 | 1240 | 0.040 |
Why?
|
Luminescent Measurements | 1 | 2018 | 341 | 0.040 |
Why?
|
NIH 3T3 Cells | 1 | 2018 | 670 | 0.040 |
Why?
|
Risk Factors | 2 | 2015 | 73806 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2005 | 4839 | 0.030 |
Why?
|
Anxiety | 2 | 2021 | 4538 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17768 | 0.030 |
Why?
|
Linear Models | 1 | 2005 | 5861 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2011 | 6457 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3705 | 0.030 |
Why?
|
Paroxetine | 2 | 2004 | 182 | 0.030 |
Why?
|
Organ Size | 1 | 2018 | 2252 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2004 | 4406 | 0.020 |
Why?
|
Functional Laterality | 1 | 2018 | 2252 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2023 | 1842 | 0.020 |
Why?
|
Natural Language Processing | 1 | 2020 | 1135 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2022 | 5199 | 0.020 |
Why?
|
Fluoxetine | 2 | 2004 | 733 | 0.020 |
Why?
|
Social Support | 1 | 2020 | 2153 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2022 | 3446 | 0.020 |
Why?
|
Neurotransmitter Uptake Inhibitors | 1 | 2007 | 36 | 0.020 |
Why?
|
Amino Acid Transport System X-AG | 1 | 2007 | 39 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5789 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2023 | 9405 | 0.020 |
Why?
|
United States | 1 | 2015 | 72140 | 0.020 |
Why?
|
Kainic Acid | 1 | 2007 | 198 | 0.020 |
Why?
|
Dicarboxylic Acids | 1 | 2007 | 77 | 0.020 |
Why?
|
Patient Selection | 1 | 2018 | 4244 | 0.020 |
Why?
|
Exploratory Behavior | 1 | 2007 | 273 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 54136 | 0.020 |
Why?
|
Pyrrolidines | 1 | 2007 | 337 | 0.020 |
Why?
|
Matched-Pair Analysis | 1 | 2004 | 283 | 0.010 |
Why?
|
Parents | 1 | 2018 | 3548 | 0.010 |
Why?
|
Neurons | 1 | 2023 | 9418 | 0.010 |
Why?
|
Connecticut | 1 | 2004 | 365 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18357 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2007 | 1844 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2018 | 18942 | 0.010 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2004 | 324 | 0.010 |
Why?
|
alpha-Methyltyrosine | 1 | 2002 | 6 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5331 | 0.010 |
Why?
|
Diphenhydramine | 1 | 2002 | 63 | 0.010 |
Why?
|
Occipital Lobe | 1 | 2003 | 373 | 0.010 |
Why?
|
Receptors, GABA | 1 | 2003 | 305 | 0.010 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2007 | 892 | 0.010 |
Why?
|
Hospitals, Veterans | 1 | 2004 | 395 | 0.010 |
Why?
|
Databases, Factual | 1 | 2017 | 7980 | 0.010 |
Why?
|
Neuroglia | 1 | 2007 | 944 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 2004 | 1032 | 0.010 |
Why?
|
Social Behavior | 1 | 2007 | 1132 | 0.010 |
Why?
|
Tryptophan | 1 | 2002 | 479 | 0.010 |
Why?
|
Norepinephrine | 1 | 2002 | 897 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2004 | 2048 | 0.010 |
Why?
|
Drug Resistance | 1 | 2004 | 1593 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41252 | 0.010 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2003 | 1132 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 39873 | 0.010 |
Why?
|
Binding Sites | 1 | 2003 | 6036 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2004 | 2634 | 0.010 |
Why?
|
Dopamine | 1 | 2002 | 1599 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2007 | 10747 | 0.010 |
Why?
|
Animals | 2 | 2018 | 167777 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2017 | 58681 | 0.010 |
Why?
|
Mice | 1 | 2018 | 81107 | 0.010 |
Why?
|
Rats | 1 | 2007 | 23681 | 0.010 |
Why?
|
Veterans | 1 | 2004 | 2631 | 0.010 |
Why?
|
Infant | 1 | 2010 | 36054 | 0.000 |
Why?
|
Child, Preschool | 1 | 2010 | 42058 | 0.000 |
Why?
|